Beneficial Ownership Report · SCHEDULE 13G/A
Standard BioTools Inc.
LABNASDAQEQUITYCurrent
Beneficial Ownership Report
Structured filing — SCHEDULE 13G/A
primary_doc.xml
Amendment · This filing reports the amendment as submitted.
Subject company
- Company
- STANDARD BIOTOOLS INC.
- Company CIK
- 0001162194
- Street
- 50 MILK STREET
- Street (continued)
- 10TH FLOOR
- City
- BOSTON
- State / country code
- MA
- Postal code
- 02109
Statement details
- Amendment number
- 3
- Security class
- Common Stock, $0.001 par value per share
- Event date
- 09/30/2026
- Rule designation
- Rule 13d-1(c)
Reporting person 1
- Name
- MAK Capital Fund LP
- Citizenship / organization
- D0
- Reporting person type
- PN
- Group designation
- a
- Aggregate amount owned
- 24,979,153.00
- Percent of class
- 6.3
- Sole voting power
- 0.00
- Shared voting power
- 24,979,153.00
- Sole dispositive power
- 0.00
- Shared dispositive power
- 24,979,153.00
- Aggregate excludes certain shares
- N
- Comments
- The calculation is based upon 24,979,153 shares of Common Stock beneficially owned as of 09/30/2026 and a total of 394,790,441 shares of Common Stock, $0.001 par value per share, outstanding as of November 1, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2026.
Reporting person 2
- Name
- MAK CAPITAL ONE LLC
- Citizenship / organization
- DE
- Reporting person type
- IA
- Group designation
- a
- Aggregate amount owned
- 24,979,153.00
- Percent of class
- 6.3
- Sole voting power
- 0.00
- Shared voting power
- 24,979,153.00
- Sole dispositive power
- 0.00
- Shared dispositive power
- 24,979,153.00
- Aggregate excludes certain shares
- N
- Comments
- The calculation is based upon 24,979,153 shares of Common Stock beneficially owned as of 09/30/2026 and a total of 394,790,441 shares of Common Stock, $0.001 par value per share, outstanding as of November 1, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2026.
Reporting person 3
- Name
- Kaufman Michael A
- Citizenship / organization
- X1
- Reporting person type
- IN
- Group designation
- a
- Aggregate amount owned
- 24,979,153.00
- Percent of class
- 6.3
- Sole voting power
- 0.00
- Shared voting power
- 24,979,153.00
- Sole dispositive power
- 0.00
- Shared dispositive power
- 24,979,153.00
- Aggregate excludes certain shares
- N
- Comments
- The calculation is based upon 24,979,153 shares of Common Stock beneficially owned as of 09/30/2026 and a total of 394,790,441 shares of Common Stock, $0.001 par value per share, outstanding as of November 1, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2026.
Item 1
Issuer
STANDARD BIOTOOLS INC.
Principal executive office address
50 MILK STREET, 10TH FLOOR, BOSTON, MASSACHUSETTS, 02109.
Item 2
Citizenship
MAK Capital Fund LP is a Bermuda limited partnership. MAK Capital One L.L.C. is a Delaware limited liability company. Mr. Kaufman is a United States citizen.
Filing person
This Schedule 13G/A is being filed by: i. MAK Capital Fund LP ("MAK Fund") ii. MAK Capital One L.L.C. ("MAK Capital"); and iii. Michael A. Kaufman ("Mr. Kaufman," and collectively with MAK Fund and MAK Capital, the "Reporting Persons")
Principal business or residence address
The principal business address of (i) MAK Fund is c/o Wakefield Quin, Victoria Place, 31 Victoria Street, Bermuda; and (ii) MAK Capital and Mr. Kaufman is 590 Madison Avenue, 31st Floor, New York, NY 10022.
Item 3
Not applicable indication
Y
Item 4
Percent of class
6.3% The calculation is based upon 24,979,153 shares of Common Stock beneficially owned as of 09/30/2026 and a total of 394,790,441 shares of Common Stock, $0.001 par value per share, outstanding as of November 1, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2026.
Amount beneficially owned
24,979,153
Sole voting power
0
Shared voting power
24,979,153
Sole dispositive power
0
Shared dispositive power
24,979,153
Item 5
Not applicable indication
Y
Item 6
Not applicable indication
Y
Item 7
Not applicable indication
Y
Item 8
Not applicable indication
Y
Item 9
Not applicable indication
Y
Item 10
Not applicable indication
N
Certifications
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Signature 1
- Reporting person
- MAK Capital Fund LP
- Signed
- /s/ Michael A. Kaufman
- Title
- Managing Member
- Date
- 11/16/2026
Signature 2
- Reporting person
- MAK CAPITAL ONE LLC
- Signed
- /s/ Michael A. Kaufman
- Title
- Managing Member
- Date
- 11/16/2026
Signature 3
- Reporting person
- Kaufman Michael A
- Signed
- /s/ Michael A. Kaufman
- Title
- Michael A. Kaufman
- Date
- 11/16/2026
Filed exhibits
- EXHIBIT 99.1 ↗ex99_1.txt
Company context
Standard BioTools Inc. (NASDAQ: LAB), is committed to setting the new standard in the life science tools industry through strategic consolidation, best-in-class operations and a world class management team. Standard BioTools’ established portfolio includes essential, standardized next-generation solutions designed to help biomedical researchers develop better therapeutics faster. Learn more at standardbio.com or connect with us on X, Facebook®, LinkedIn, and YouTube™.